Last reviewed · How we verify
Slow Progression of Coronary Artery Disease
Approved treatments
- Inosital
Inosital works by influencing the metabolism of lipids in the body. - Lescol · Novartis
Fluvastatin sodium inhibits HMG-CoA reductase, reducing cholesterol biosynthesis and increasing LDL receptor activity, lowering plasma cholesterol. - Lipitor · Pfizer Inc.
Selective competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis. - Zocor · Merck & Co.
- Myoinositol · University of Colorado, Denver
- Lipitor · Pfizer
Lipitor is a selective, competitive inhibitor of HMG-CoA reductase, a key enzyme in cholesterol synthesis. - Mevacor · Merck & Co.
Mevacor works by inhibiting the enzyme HMG-CoA reductase, which plays a key role in cholesterol production in the liver.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Slow Progression of Coronary Artery Disease patent landscape — cliff calendar, originator estates, attackable patents
- Slow Progression of Coronary Artery Disease treatment landscape brief
- Slow Progression of Coronary Artery Disease treatment updates RSS
Frequently asked questions about Slow Progression of Coronary Artery Disease
What drugs treat Slow Progression of Coronary Artery Disease?
Tracked treatments include Inosital, Lescol, Lipitor, Zocor, Myoinositol, Mevacor.
What is the treatment for Slow Progression of Coronary Artery Disease?
Standard treatment for Slow Progression of Coronary Artery Disease includes Inosital, Lescol, Lipitor, Zocor, Myoinositol. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Slow Progression of Coronary Artery Disease patent cliff · Slow Progression of Coronary Artery Disease CI report
- Treatment: Inosital
- Treatment: Lescol · Novartis
- Treatment: Lipitor · Pfizer Inc.
- Treatment: Zocor · Merck & Co.
- Treatment: Myoinositol · University of Colorado, Denver
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing